SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GLGC Gene Logic
An SI Board Since July 1998
Posts SubjectMarks Bans Symbol
360 30 0 GLGC
Emcee:  Steven Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
210Designing an Effective Preclinical Profiling Strategy genengnews.comMike McFarland-12/14/2005
209OT Iconix iconixpharm.com 11/17/2005 Iconix Pharmaceuticals Announces ChemogenMike McFarland-11/20/2005
208Guessing that glgc is spending money on the wrong stuff (CRO work) when they shoMike McFarland-6/24/2005
207Gene Logic Expands Contract Study Services Capacity phx.corporate-ir.netMike McFarland-6/9/2005
206Gene Logic Announces Takeda Extension of BioExpress System Subscription Gene LMike McFarland-6/7/2005
205Yes! Dog and pony shows are, well, for the dogs. The less they deal with investMike McFarland-6/6/2005
204Mike; Not sure what you are saying? That it is better to stick to the science aSteve Lokness-6/6/2005
203The GLGC website currently lists no upcoming investor conferences. GOOD! And tMike McFarland-6/6/2005
202I have said goodbye to the yahoo thread, and am signing off here as well. I'Mike McFarland-4/27/2005
201Steve, In a human genetic association study, dcgn first identified a pathway cokeokalani'nui-4/24/2005
200Upcoming scientfic conferences: 04/27/2005 - 04/28/2005 2005 FDA Science ForumMike McFarland-4/24/2005
199eeek, a mouse! Of course, I meant to type mouse imaging.Mike McFarland-4/23/2005
198From an interview with Tartaglia "finding new indications for failed compoMike McFarland-4/23/2005
197Isn't Perlegen and DCGN doing almost the same thing - but while Perlegen is Steve Lokness-4/23/2005
196<i>for smallish populations?</i> No. You and me type populations. keokalani'nui-4/22/2005
195<dcgn is capturing most of the development upside> maybe that is built intMike McFarland-4/22/2005
194Not saying glgc and dcgn are at all similar, but for an answer to this <i>keokalani'nui-4/22/2005
193The call was nearly all junk about slightly different margins here than there, yMike McFarland-4/22/2005
192Mike; If the 7 candidates are from failed efforts - what is the strategy to getSteve Lokness-4/22/2005
191Just finished listening to the first quarter call, which was pretty good--howevMike McFarland-4/22/2005
190Fairly substantial blocks being traded at $2.85 today. I have to beleive that weMike McFarland-4/18/2005
189Just seems odd to give minus 9 million to this. Obviously, alot of PR is fluff, Mike McFarland-4/16/2005
188Market Cap, 91.73M Enterprise Value (15-Apr-05)³: -8.28M <<<<&lMike McFarland-4/15/2005
187biomarkers/pharmacogenomics bioitworld.com lifescience-insights.comMike McFarland-3/31/2005
186Toxicogenomics Data: The Road to Acceptance ehp.niehs.nih.gov (Iconix, Gene LogMike McFarland-3/24/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News